INEM External seminar 2026
Thomas HENRY, DR, CIRI-Centre International de Recherche en Infectiologie, Inserm U1111, CNRS UMR5308, ENS Lyon, Univ Lyon, : « From antibacterial immune responses to autoinflammatory syndromes: Pyrin inflammasome and ALPK1 pathway »
Daniel Boehmer, MD, PhD, Department of Medicine II, University Hospital, LMU Munich, Germany.Title: « Type III Interferons in intestinal inflammation. »
Claire Monge, PhD, Laboratory of Tissue Biology and Therapeutic Engineering (LBTI) Institute of Biology and Protein Chemistry (IBCP), Lyon.
Benoit Chassaing, PhD, Département de Microbiologie, Institut Pasteur, INSERM, Université Paris Cité. Title : « Diet-microbiota interactions – A personalized point of view. »
Heloïde Rytter, PhD, Département de Microbiologie, Institut Pasteur, INSERM, Université Paris Cité. Title : « Individualized sensitivity to food additives: from prediction to mechanisms. »
INEM External seminar 2025
Dr Mo Chunheng, Associate Professor, West China Second University Hospital, China Title : « Targeting Ferroptosis in the Vascular Niche Promotes Lung Regeneration to Alleviate Fibrosis. »
Dr Pauline Cantin, University of Tours – INRAE ISP 1282 Title : “Vaccination against toxoplasmosis in wildlife species in zoological parks and Study of the immune response induced by a candidate subunit vaccine”
Dr Mathieu Cinier, Dr Raphaelle Dréan, Affilogic : Advances of the Nanofitin technology
Dr Tomasz Wypych, Laboratory of host-microbiota interactions, Nencki Institute of Experimental Biology, Warsaw, Poland. Title : “Microbiota/metabolites and lung disease”
Raphael Sanches Peres, University of Sao Paulo. Title : “Exploring the Impact of Regulatory T Cell Responses in Inflammatory Bowel Diseases”
Dr Jochem Bernink, Uni clinic Amsterdam. Title : “Tuft cells act as regenerative stem cells in the human intestine”
Dr Aurélie Balvay, INRAe Jouy en Josas, Title: “Gnotobiotic mice in research”
Dr Izïa Larrigaldie, INRAe Dijon, Title : “Perception de différentes odeurs humaines par certains ruminants et les conséquences sur leurs comportements”.
Pratik Gajane, CPJ, LIFO Orleans. Title : “Advancing Personalized and Fair Chronic Pain Care using Reinforcement Learning”.
Pablo Pelegrin Vivancos, « Molecular Inflammation Research », IMIB (Instituto Murciano de Investigacion Biosanitaria), Université de Murcie, Espagne Title : “Translating inflammasomes: a journey from bench to bedside”
INEM External seminar 2024
June 25
Raphael Rodrigues, Institut Curie, Paris: Chemical control of cell plasticity
March 14
Pr Tim Sparwasser, University of Mainz: « Metabolic checkpoints for the treatment of autoimmune diseases »
February 6
Dr Chloé Michaudel, INRAe Université Paris-Saclay, INRAe, AgroParisTech, Micalis institut « IBD and tryptophane metabolites via AHR and STING in the DsS colitis model »
January 23
Pr Stefan Dimitrov, University Grenoble, IMB, Sofia: « Epigenetics Meets Immunity and Inflammation »
INEM External seminar 2023
November 23
Dr Marcin Suskiewicz (CBM Orléans) « Mechanisms of protein regulation by modifications: phosphorylation, ADP-ribosylation, and ubiquitylation »
November 30
Dr Leslie Chavez, Uni Mexico City: COVID lung fibrosis
October 23
Dr Tiphaine Voisin (Infinity Toulouse) « Transcriptional reprogramming of skin-innervating sensory neurons in allergic contact dermatitis »
October 14
Dr Olivier Burgy (Univ Bourgogne) « Deciphering extracellular vesicle cargo and its implications for pulmonary fibrosis »
October 03
Pr Nathalie Boulanger (UR7290 Virulence précoce, Uni Strasbourg) « Proteomics to identify vaccine candidates at the cutaneous interface in Lyme borreliosis »
September 19
Dr Abdelhadi Saoudi (Infinity Inserm U1291, Toulouse) « Contribution of genetic and environmental factors to susceptibility to inflammatory diseases of the central nervous system »
September 12
Dr Hervé Boutin (iBrain, Tours) « Impact of inflammation and neuroinflammation in Alzheimer’s disease »
June 5
Pr Ken Lau and Andrea Rolong, at Delegation CNRS, salle Sadron : Cell plasticity at interface of inflammation, in organoids
June 13
Dr Marcin Suskiewicz, CBM. Mechanisms of protein regulation by modifications: phosphorylation, ADP-ribosylation, and ubiquitylation
June14
Dr Marc Le Bert, INEM. Organoid cultures for research
June 15
Lucjia Leko, Msc candidate, Zagreb University. « GPR109A controls IMQ induce psoriasis »
June 19
Pr Marco Aurelio Vinolo, Univ Campinas, Brazil « Investigating the host-microbiota interactions at the single cell level »
June 20
Pr Isabelle Brunet du Collège de France. « Vascularisation du système nerveux périphérique »
June 20
Pr Hosana Gomes Rodrigues, Univ Campinas, Brazil « Oleic acid reduces Imiquimod-induced psoriasis »
June 22
Pr Remo Russo, Studium project UFMG Epithelial chemokine in lung fibrosis
Apr 26
Dr Mathias Chamaillard, Inserm Lille « NOD2 and infant growth » ,
Apr 14
David Rios Covian, INRAe MICALIS institute « Microbial-derived branched chain short fatty acids: metabolism and interactions with the host »
March 21
Prof Qui Yui, Shenzhen Institute of Advanced Technology « NAD+ metabolism in disease models »
Feb 28
Dr Lionel Apetoh, Christopher Brown Professor of Immunology at Indiana University School of Medicine « Harnessing T cell effector functions for cancer immunotherapy. »
Jan 17
Francois Legou, INSERM ERL1305, Rennes « MAIT cells and riboflavin metabolites in host – microbiota interactions »
INEM External seminar 2022
November 9
Prof. Jose C. Alves-Filho, Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Brazil Molecular control of Th17 cell pathogenicity in autoimmune disease
Prof. Sandra Y. Fukada, Department of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Brazil Immunological mechanisms involved in bone remodeling
November 14
Progress Report Ador Thomas (Direction de these Menuet A, Encadrant Delalande A) : Thérapie génique dans le syndrome de l’X Fragile, approche par sonoporation focalisée.
November 16
Prof. Jose C. Alves-Filho, Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Brazil. Control of regulatory T cell homeostasis and function by Adenosine
Prof. Sandra Y. Fukada, Department of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Brazil Metabolic changes in osteoclasts determines the bone biology
October 4
Coen Wiegmann, UCL Ozone effects on mouse and human cells ?
October 11
Benoit Briard , CEPR, Inserm Tours: Inflammasome regulation during bacterial-fungal superinfection in cystic fibrosis disease
October 28
Thierry Bouyssou, Boehringer Ingelheim. TrpC6 inhibitors for ARDS.
September 1
Atlante Mendes, PhD student, USP, Brazil Nerve injury in GPR109 and cGAS dependent neurotoxicty by cis-platin
September 13
Jean-Marc Bonmatin, CBM Orleans Pesticides– Neurotoxiques néonicotinoïdes et Mitotoxiques fongicide type SDHIs
September 20
Aurélien Trompette, UNIL, Lausanne, Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation
September 21
Timna Martins, USP Ribeirao Preto, Brazil. Psoriasis-Inflammation activation
September 30
Jean-Baptiste Renard, CNRS –PM2.5 pollution and health
June 7
Chantal Pichon, CBM Orleans, Therapeutic applications of messenger RNA: Hopes and challenges
June 14
Adam Cunningham, Birmingham, UK Multi-systems inflammation
May 3
Thirumala Kanneganti, St. Jude Children’s Research Hospital, Menphis, TN, USA ZBP1-mediated immune response and PANoptosis
May 10
Pascal Auzou, CHR Orléans Clinical research on fNIRS
May 24
Philippe Langella, INRA, Jouy en Josas Microbes regulating inflammation
May 31
Sophie Ugolini, CIML Marseille TAFA4 mediating sensing of skin radiation injury
April 5
Nicolas Gaudenzio, Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) Neuro-immune regulation in mucosa and skin.
April 28
Olivier Lamiable, Malaghan org., New Zeland Innate lymphoid cells and IL-13 drive the functional specialization of dendritic cells in the skin
Mars 8
Patrick Legembre, INSERM CD95/Fas, a TNF receptor family member, triggers inflammatory diseases 24
February 15
Charaf Benarafa, VetSuisse, Bern University, Switzerland Experimental studies on SARS-Cov2 in mice
February 22
Gerard Burgstaller, Helmoltz Zentrum München, Germany Drug screening in human fibrosis model new target
January 11
Delphine Sterlin, Hôpital Salpetrière, Paris Human IgA coat a diverse array of commensal bacteria
January 13
Jose Torero, UCL UK (invited Professor ICARE) Fire related air pollution issues and human health
January 25
Bruno Marcel Melo, USP, Brazil 100A9 drives the chronification of psoriasiform inflammation by regulating cutaneous type-3
immunity
